Synaptogenix, Inc.
SNPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | – | 100% | – | 50% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | – | -58,935.1% | – | -40,085.2% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | – | -442,101.9% | – | -102,108.4% |
| EPS Diluted | -1.56 | -11.26 | 0.12 | -4.58 |
| % Growth | 86.1% | -9,483.3% | 102.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |